Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Growth Large Cap
  • Asset Class: Equity
  • Geographic Focus: U.S.

American Century NT Equity Growth Fund

+ Add to Watchlist

ACLEX:US

12.25 USD 0.03 0.25%

As of 09:29:30 ET on 03/27/2015.

Snapshot for American Century NT Equity Growth Fund (ACLEX)

Year To Date: -0.67% 3-Month: -1.94% 3-Year: +15.44% 52-Week Range: 11.03 - 12.65
1-Month: -2.10% 1-Year: +11.89% 5-Year: +14.61% Beta vs SPX: 1.02

Mutual Fund Chart for ACLEX

No chart data available.
  • ACLEX:US 12.25
  • 1M
  • 1Y
Interactive ACLEX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ACLEX

American Century NT Equity Growth Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital growth. The Fund invests primarily from the 1,500 largest publicly traded U.S. companies. The managers use quantitative, computer-driven models to construct the portfolio of stocks for the fund.

Inception Date: 05-12-2006 Telephone: 1-816-531-5575
Managers: BILL MARTIN / CLAUDIA MUSAT
Web Site: www.americancentury.com

Fundamentals for ACLEX

NAV (on 2015-03-27) 12.25
Assets (M) (on 2015-02-27) 1,300.15
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for ACLEX

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-03-10) 0.05
Dividend Yield (ttm) 12.09

Fees & Expenses for ACLEX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.47
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 0.47

Top Fund Holdings for ACLEX

Filing Date: 12/31/2014
Name Position Value % of Total
Apple Inc 333,777 36,842,305 2.994%
Microsoft Corp 747,004 34,698,336 2.820%
Johnson & Johnson 276,358 28,898,756 2.349%
Intel Corp 648,608 23,537,984 1.913%
Pfizer Inc 723,498 22,536,963 1.832%
Oracle Corp 465,203 20,920,179 1.700%
Merck & Co Inc 350,272 19,891,947 1.617%
Cisco Systems Inc 712,553 19,819,662 1.611%
Amgen Inc 122,956 19,585,661 1.592%
Gilead Sciences Inc 192,443 18,139,677 1.474%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil